|
DE69535104T2
(de)
*
|
1994-11-08 |
2007-02-08 |
Avicena Group, Inc., Cambridge |
Verwendung von kreatin oder kreatinanologen zur behandlung von huntington chorea, morbus parkinson und amyotrophen lateralsklerose
|
|
IT1283967B1
(it)
*
|
1996-03-29 |
1998-05-07 |
Sigma Tau Ind Farmaceuti |
Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
|
|
GB9611356D0
(en)
*
|
1996-05-31 |
1996-08-07 |
Howard Alan N |
Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
|
|
US7150880B2
(en)
|
1996-05-31 |
2006-12-19 |
The Original Creatine Patent Co. Ltd. |
Compositions containing creatine and creatinine and a methyl xanthine
|
|
US6524611B2
(en)
|
1996-05-31 |
2003-02-25 |
The Howard Foundation |
Compositions containing creatine and creatinine
|
|
US6168802B1
(en)
|
1996-05-31 |
2001-01-02 |
The Howard Foundation |
Compositions containing creatine and aloe vera extract
|
|
US8128955B2
(en)
|
1996-05-31 |
2012-03-06 |
The Original Creatine Patent Company |
Food compositions containing creatine
|
|
US6274161B1
(en)
|
1996-05-31 |
2001-08-14 |
The Howard Foundation |
Compositions containing creatine in suspension
|
|
DE19649891C2
(de)
*
|
1996-12-02 |
1998-12-10 |
Mk Produktkontor Gmbh |
Verwendung von antioxidativen Zusammensetzungen mit Süßmolkekonzentrat
|
|
CA2280093A1
(en)
*
|
1997-02-04 |
1998-08-06 |
John V. Kosbab |
Compositions and methods for prevention and treatment of vascular degenerative diseases
|
|
RU2141483C1
(ru)
*
|
1997-07-04 |
1999-11-20 |
Небольсин Владимир Евгеньевич |
Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
|
|
DE19806890A1
(de)
*
|
1998-02-19 |
1999-08-26 |
Beiersdorf Ag |
Kosmetische und dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Antioxidans sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
|
|
AU759467B2
(en)
*
|
1998-04-02 |
2003-04-17 |
Avicena Group, Inc. |
Compositions containing a combination of a creatine compound and a second agent
|
|
US20060128671A1
(en)
*
|
1998-04-02 |
2006-06-15 |
The General Hospital Corporation |
Compositions containing a combination of a creatine compound and a second agent
|
|
IT1299191B1
(it)
*
|
1998-06-23 |
2000-02-29 |
Sigma Tau Healthscience Spa |
Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
|
|
US6149924A
(en)
*
|
1998-07-20 |
2000-11-21 |
Biomed Research & Technologies, Inc. |
Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
|
|
JP4703851B2
(ja)
|
1998-07-30 |
2011-06-15 |
シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ |
Ｌ−カルニチンおよびそのアルカノイル誘導体の、抗癌作用を有する医薬品の製造のための使用
|
|
AU5334899A
(en)
*
|
1998-08-04 |
2000-02-28 |
Kosbab, John V. |
Nutrient and therapeutic compositions for the treatment of cancer
|
|
IT1302863B1
(it)
*
|
1998-11-13 |
2000-10-10 |
Sigma Tau Healthscience Spa |
Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
|
|
NO993678L
(no)
*
|
1999-07-28 |
2001-01-29 |
Norsk Hydro As |
Fôr for salmonider
|
|
US6294579B1
(en)
|
1999-10-11 |
2001-09-25 |
Joseph W. Carnazzo |
Method for improving delivery of tyrosine supplementation
|
|
AUPQ515000A0
(en)
*
|
2000-01-19 |
2000-02-10 |
Grigg, Geoffrey Walter |
Treatment of uv induced immunosuppression
|
|
US8753675B1
(en)
*
|
2000-01-20 |
2014-06-17 |
Raj K. Chopra |
Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
|
|
US6476010B2
(en)
|
2000-03-10 |
2002-11-05 |
Hill's Pet Nutrition |
Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
|
|
US8252309B2
(en)
*
|
2000-04-04 |
2012-08-28 |
Sigma-Tau Industrie Farmaceutiche Riunite Spa |
Dietary supplement energy-providing to skeletal muscles
|
|
IT1317008B1
(it)
*
|
2000-04-04 |
2003-05-26 |
Sigma Tau Healthscience Spa |
Integratore alimentare energizzante sulla muscolatura scheletrica eprotettivo sull'apparato cardiovascolare.
|
|
AU2001290939B2
(en)
*
|
2000-09-14 |
2005-06-16 |
Board Of Regents Of The University Of Nebraska |
Creatine ester pronutrient compounds and formulations
|
|
US20030212136A1
(en)
|
2001-09-14 |
2003-11-13 |
Vennerstrom Jonathan L. |
Creatine ester pronutrient compounds and formulations
|
|
JPWO2002076455A1
(ja)
*
|
2001-03-16 |
2004-07-08 |
サントリー株式会社 |
自律神経調節作用剤及び健康飲食物
|
|
EP1567180A4
(en)
*
|
2002-06-04 |
2010-03-10 |
Avicena Group Inc |
METHODS OF TREATING COGNITIVE DYSFUNCTIONS BY MODULATING BRAIN ENERGY METABOLISM
|
|
US6793193B2
(en)
*
|
2002-08-20 |
2004-09-21 |
Dart Industries Inc. |
Adjustable mold for forming shaped food
|
|
US7795203B2
(en)
*
|
2002-09-30 |
2010-09-14 |
Babizhayev Mark A |
Method for topical treatment of eye disease and composition and device for said treatment
|
|
WO2004064866A1
(ja)
*
|
2003-01-20 |
2004-08-05 |
Innovative Vision Products, Inc. |
カルノシナーゼ阻害剤とｌ−カルノシン類との併用および組成物
|
|
RU2255758C2
(ru)
*
|
2003-09-18 |
2005-07-10 |
Закрытое акционерное общество "Научно-производственное объединение "ТЕХКОН" |
Биологически активный карнозин-анзеринсодержащий комплекс и способ его получения
|
|
PL2233127T3
(pl)
|
2004-03-17 |
2020-11-16 |
Stada Arzneimittel Ag |
Zastosowanie przeciwutleniaczy do wytwarzania kompozycji farmaceutycznej lub kosmetycznej do ochrony skóry przed uszkodzeniem wywołanym przez promieniowanie podczerwone
|
|
US20080194493A1
(en)
|
2004-06-08 |
2008-08-14 |
Giancarlo Aldini |
Compositions Containing D-Carnosine
|
|
JP2006052186A
(ja)
*
|
2004-08-16 |
2006-02-23 |
Toagosei Co Ltd |
新規ジヒドロフェルラ酸縮合物
|
|
WO2006026304A1
(en)
*
|
2004-08-25 |
2006-03-09 |
Ivax Corporation |
Cardioprotective formulations and uses thereof
|
|
CN101309688B
(zh)
|
2005-05-23 |
2016-06-22 |
自然选择国际公司 |
持续释放β-丙氨酸的组合物和方法
|
|
EP2468272A1
(en)
*
|
2006-05-11 |
2012-06-27 |
Avicena Group, Inc. |
Methods of treating a neurological disorder with creatine monohydrate
|
|
RU2318512C1
(ru)
*
|
2006-09-01 |
2008-03-10 |
ГУ Научно-исследовательский институт психического здоровья Томского научного центра Сибирского отделения Российской академии медицинских наук ГУ НИИ психического здоровья ТНЦ СО РАМН |
Способ реабилитации больных алкоголизмом на этапе формирования ремиссии
|
|
US9421262B2
(en)
*
|
2009-10-28 |
2016-08-23 |
Biomed Research & Technologies, Inc. |
Compositions and methods for treating dermatological conditions
|
|
WO2011078204A1
(ja)
*
|
2009-12-24 |
2011-06-30 |
浜理薬品工業株式会社 |
高脂血症の予防または治療剤、および抗疲労剤
|
|
MX2013007189A
(es)
*
|
2010-12-21 |
2013-07-12 |
Nestec Sa |
Metodos y composiciones adecuados para manejar glucosa en sangre en animales.
|
|
US9233099B2
(en)
|
2012-01-11 |
2016-01-12 |
University Of Cincinnati |
Methods of treating cognitive dysfunction by modulating brain energy metabolism
|
|
JP2014114244A
(ja)
*
|
2012-12-11 |
2014-06-26 |
Ito En Ltd |
抗疲労剤組成物
|
|
JP6401028B2
(ja)
*
|
2014-11-27 |
2018-10-03 |
Ｓｈｉｏｄａライフサイエンス株式会社 |
鯨筋肉抽出物からなる中長期記憶障害予防改善剤
|
|
JP2016130229A
(ja)
*
|
2015-01-15 |
2016-07-21 |
有限会社アント |
アミノ酸溶解物の製造方法および該製造方法により製造したアミノ酸溶解物
|
|
FR3056381B1
(fr)
*
|
2016-09-26 |
2019-11-15 |
Futur Optimal |
Composition comprenant de la carnosine
|
|
JOP20190146A1
(ar)
|
2016-12-19 |
2019-06-18 |
Axcella Health Inc |
تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
|
|
BR112020002419A2
(pt)
|
2017-08-14 |
2020-07-28 |
Axcella Health Inc. |
aminoácido para o tratamento de doença do fígado
|
|
EP3810123A1
(en)
|
2018-06-20 |
2021-04-28 |
Axcella Health Inc. |
Compositions and methods for the treatment of fat infiltration in muscle
|
|
US20220218640A1
(en)
*
|
2021-01-14 |
2022-07-14 |
Rob Dickerman |
Amino acid delivery system
|
|
JP2023156812A
(ja)
*
|
2022-04-13 |
2023-10-25 |
サントリーホールディングス株式会社 |
組成物
|